The study, published in JAMA Network Open, followed 3997 patients who had surgery after a COVID-19 infection. Patients underwent surgery anywhere from 30 days to 225 days, with a median time of 98 days post-infection. Only 12.1 percent of patients experienced a postoperative major heart event.
Increasing the time between infection and surgery was associated with decreased risk of cardiovascular events in both vaccinated and unvaccinated patients.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
